BioSpace News Archive

Pharm Country

STRATA Skin Sciences Announces 1-for-10 Reverse Stock Split

STRATA Skin Sciences, Inc. announces that it will effect a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-10 that will become effective at 11:59 p.m. Eastern Time on June 6, 2024.

April 26, 2024
·
4 min read
Business

Rakovina Therapeutics Inc. Announces 2023 Financial Results and Provides Corporate Update

Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and provided a corporate update.

April 26, 2024
·
6 min read
Business

Bio-Rad Announces Life Science Group Management Changes

Bio-Rad Laboratories, Inc. today announced the promotion of James J. Barry, currently Senior Vice President of Global Manufacturing, to the position of Executive Vice President and President of the Life Science Group, effective May 1, 2024.

April 26, 2024
·
2 min read
Business

Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments

Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments.

April 26, 2024
·
9 min read
Biotech Bay

Amgen to Submit Teprotumumab Marketing Authorization Application to the European Medicines Agency

Amgen announced the imminent submission of a Marketing Authorization Application to the European Medicines Agency for teprotumumab, a fully human monoclonal antibody and targeted inhibitor of the insulin-like growth factor-1 receptor, for the treatment of moderate to severe Thyroid Eye Disease in adults.

April 26, 2024
·
13 min read
Biotech Bay

Invensify Introduces the Industry’s Most Energy Efficient Cold Chain Shipping Transporter

Invensify, Inc. temperature-controlled shipping container designed to maintain stable storage temperatures for high-value pharmaceuticals before and during transport to last-mile cold chain destinations.

April 26, 2024
·
2 min read
BioMidwest

C2N Diagnostics Expands Into Japan Through Mediford Corporation Partnership With Precivity™ Blood Testing for Alzheimer’s Disease and Brain Research Market

C₂N Diagnostics, LLC announced a partnership agreement with Mediford Corporation, a PHC Holdings Corporation Group Company and premier provider of clinical research to the biopharma industry throughout Japan.

April 26, 2024
·
6 min read
Genetown

Variantyx Secures $36M Investment As Testing Demand And Market Share Continues To Increase

Variantyx, a leader in molecular diagnostics, announced that it has secured an additional $36 million in funding from its portfolio of investors which includes Peregrine Ventures, Pitango HealthTech, New Era Capital Partners and Bosch Ventures.

April 26, 2024
·
2 min read
Deals

Sino Biological Finalizes the Acquisition of SignalChem Biotech, Strengthening Global Presence and Expanding Product Portfolio

Sino Biological, Inc. (“Sino Biological” or the “Company”), a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), specializing in...

April 26, 2024
·
4 min read
Business

Repare Therapeutics Appoints Steven H. Stein, M.D. to its Board of Directors

Repare Therapeutics Inc., a leading clinical-stage precision oncology company, announced the appointment of Steven H. Stein, M.D., to its Board of Directors, effective as of the date of the Company’s upcoming annual meeting of shareholders in June 2024.

April 26, 2024
·
3 min read